ES2149734T1 - Metodo para la preparacion de citalopram. - Google Patents

Metodo para la preparacion de citalopram.

Info

Publication number
ES2149734T1
ES2149734T1 ES97945799T ES97945799T ES2149734T1 ES 2149734 T1 ES2149734 T1 ES 2149734T1 ES 97945799 T ES97945799 T ES 97945799T ES 97945799 T ES97945799 T ES 97945799T ES 2149734 T1 ES2149734 T1 ES 2149734T1
Authority
ES
Spain
Prior art keywords
formula
citalopram
compound
followed
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES97945799T
Other languages
English (en)
Other versions
ES2149734T3 (es
Inventor
Hans Petersen
Peter Bregnedal
Klaus Peter Bogeso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of ES2149734T1 publication Critical patent/ES2149734T1/es
Application granted granted Critical
Publication of ES2149734T3 publication Critical patent/ES2149734T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/68Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un método para la preparación de citalopram, que comprende las etapas de: a) hacer reaccionar un compuesto de Fórmula IV Fórmula IV en la que R1 es H o alquil C1-6-carbonilo, con un reactivo de Grignard de 4-halógeno-fluorofenilo; b) hacer reaccionar el compuesto resultante de Fórmula V Fórmula V en la que R1 se define como antes, con un reactivo de Grignard de 3-halógeno-N,N-dimetilpropilamina: c) efectuar el cierre de anillo del compuesto resultante de Fórmula VI Fórmula VI en la que R1 se define como antes, y d) convertir el compuesto resultante de Formula VII Fórmula VII en la que R1 se define como antes en el correspondiente 5- ciano-derivado, es decir, citalopram a) cuando R1 es alquil C1-6-carbonilo, por hidrólisis de grupo alquil C1-6-carbonilamino, R1-NH-, al correspondiente grupo amino en el que R1 es H, seguida de diazotación y reacción con CN-, y b) cuando R1 es H por diazotación seguida de reacción con CN-, seguido por aislamiento de citalopramcomo base o sal farmaceuticamente aceptable del mismo.
ES97945799T 1997-11-11 1997-11-11 Metodo para la preparacion de citalopram. Expired - Lifetime ES2149734T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN97182416A CN1286687A (zh) 1997-11-11 1997-11-11 制备西酞普兰的方法
PCT/DK1997/000513 WO1998019512A2 (en) 1997-11-11 1997-11-11 Method for the preparation of citalopram

Publications (2)

Publication Number Publication Date
ES2149734T1 true ES2149734T1 (es) 2000-11-16
ES2149734T3 ES2149734T3 (es) 2003-02-16

Family

ID=37709785

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97945799T Expired - Lifetime ES2149734T3 (es) 1997-11-11 1997-11-11 Metodo para la preparacion de citalopram.

Country Status (20)

Country Link
US (1) US6258842B1 (es)
EP (1) EP1042310B1 (es)
JP (1) JP3813820B2 (es)
CN (1) CN1286687A (es)
AT (1) ATE221522T1 (es)
AU (1) AU738359B2 (es)
BR (1) BR9714925A (es)
CA (1) CA2291072C (es)
CZ (1) CZ292911B6 (es)
DE (2) DE1042310T1 (es)
DK (1) DK1042310T3 (es)
EA (1) EA002770B1 (es)
ES (1) ES2149734T3 (es)
HU (1) HUP0002953A3 (es)
IS (1) IS2009B (es)
SK (1) SK283907B6 (es)
TR (1) TR200001341T2 (es)
UA (1) UA62984C2 (es)
WO (1) WO1998019512A2 (es)
ZA (1) ZA9810058B (es)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
KR100411505B1 (ko) * 1998-10-20 2003-12-18 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
CA2356188C (en) 1998-12-23 2006-05-23 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
ATE237604T1 (de) 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991486A1 (it) * 1999-07-06 2001-01-06 Vis Farmaceutici S P A Processo per la sintesi di citalopram
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
DE69920526T2 (de) 1999-10-25 2006-02-23 H. Lundbeck A/S Verfahren zur herstellung von citalopram
ES2229774T3 (es) 1999-10-25 2005-04-16 H. Lundbeck A/S Metodo para la preparacion de citalopram.
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
SI1246812T1 (en) 1999-12-28 2004-08-31 H. Lundbeck A/S Method for the preparation of citalopram
HUP0203840A3 (en) * 1999-12-30 2005-02-28 Lundbeck & Co As H Method for the preparation of citalopram
IL150561A0 (en) 2000-01-14 2003-02-12 Lundbeck & Co As H Method for the preparation of 5-cyanophthalide
NL1017415C1 (nl) 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
CN1429219A (zh) 2000-03-13 2003-07-09 H·隆德贝克有限公司 制备西酞普兰的方法
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
CA2402553A1 (en) 2000-03-13 2001-09-20 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
ATE257832T1 (de) 2000-03-14 2004-01-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
TR200202168T2 (tr) * 2000-03-16 2002-12-23 H. Lundbeck A/S 5-Siyano-1-(4-Florofenil)-1,3-Dihidroizobenzofuranların preparasyon metodu
AR032455A1 (es) * 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
US6879110B2 (en) * 2000-07-27 2005-04-12 Semiconductor Energy Laboratory Co., Ltd. Method of driving display device
FI20011621A (fi) * 2000-08-18 2002-02-19 Lundbeck & Co As H Menetelmä sitalopraamin valmistamiseksi
IT1319686B1 (it) * 2000-12-12 2003-10-23 C D Farmasint S R L Procedimento di preparazione di citalopram.
EA003581B1 (ru) * 2000-12-22 2003-06-26 Х.Лундбекк А/С Способ получения чистого циталопрама
DE10112828C1 (de) * 2000-12-28 2002-11-21 Lundbeck & Co As H Verfahren zur Herstellung von Citalopram
EA003459B1 (ru) * 2000-12-28 2003-06-26 Х.Лундбекк А/С Способ получения чистого циталопрама
CA2435925A1 (en) 2001-01-30 2002-08-08 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
EA200301195A1 (ru) * 2001-05-01 2004-04-29 Х. Лундбекк А/С Применение энантиомерно чистого эсциталопрама
BG65271B1 (bg) * 2001-06-18 2007-11-30 H. Lundbeck A/S Метод за получаване на циталопрам
EA006213B1 (ru) 2001-07-31 2005-10-27 Х. Лундбекк А/С Кристаллическая композиция, содержащая эсциталопрам
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
US7148364B2 (en) 2002-01-07 2006-12-12 Sun Pharmaceutical Industries Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile
HU0200980D0 (es) * 2002-03-14 2002-05-29 Gabor S Pal Dr
BG65515B1 (bg) * 2002-07-26 2008-10-31 H. Lundbeck A/S Метод за получаване на 5-цианофталид
TWI306846B (en) 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
ITMI20030479A1 (it) * 2003-03-13 2004-09-14 Adorkem Technology S P A Procedimento per la preparazione di un ciano-isobenzofurano.
US6781003B1 (en) * 2003-06-09 2004-08-24 Aurobindo Pharma Ltd. Preparation of pure citalopram
EP1486492A3 (en) 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
EP1506963B1 (en) * 2003-10-28 2005-04-13 Adorkem Technology SpA Method for the preparation of citalopram
CN100569765C (zh) 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
WO2006021971A2 (en) 2004-08-23 2006-03-02 Sun Pharmaceutical Industries Limited 'process for preparation of citalopram and enantiomers'
WO2006103550A1 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Processes for the preparation of citalopram and its intermediate 5-aminophthalide
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
CN100391952C (zh) * 2005-07-12 2008-06-04 广东西陇化工有限公司 西酞普兰盐的制备方法
US9339500B2 (en) * 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
CN105801329B (zh) * 2016-04-29 2017-11-28 阜阳欣奕华材料科技有限公司 一种晕苯的制备方法
CN105801333B (zh) * 2016-04-29 2017-12-22 江苏佳麦化工有限公司 一种晕苯的制备方法
CN105801328B (zh) * 2016-04-29 2017-12-08 浙江瑞灿科技有限公司 一种晕苯的制备方法
CN106748627A (zh) * 2016-11-14 2017-05-31 苏州市罗森助剂有限公司 一种一锅法制备3,5‑二甲基溴苯的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (es) 1965-03-18
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
NZ243065A (en) 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram

Also Published As

Publication number Publication date
ATE221522T1 (de) 2002-08-15
WO1998019512A2 (en) 1998-05-14
AU5116898A (en) 1998-05-29
JP3813820B2 (ja) 2006-08-23
SK6822000A3 (en) 2000-10-09
DE69714480D1 (de) 2002-09-05
IS5461A (is) 2000-04-18
CZ292911B6 (cs) 2004-01-14
UA62984C2 (en) 2004-01-15
BR9714925A (pt) 2003-07-22
CN1286687A (zh) 2001-03-07
IS2009B (is) 2005-05-13
HUP0002953A2 (hu) 2001-04-28
AU738359B2 (en) 2001-09-13
JP2002530295A (ja) 2002-09-17
ES2149734T3 (es) 2003-02-16
EP1042310A2 (en) 2000-10-11
ZA9810058B (en) 1999-05-05
WO1998019512A3 (en) 1998-08-13
DE69714480T2 (de) 2003-03-06
TR200001341T2 (tr) 2000-11-21
DK1042310T3 (da) 2002-12-02
US6258842B1 (en) 2001-07-10
DE1042310T1 (de) 2001-04-19
EA200000511A1 (ru) 2000-10-30
EP1042310B1 (en) 2002-07-31
CZ20001736A3 (cs) 2000-10-11
CA2291072A1 (en) 1998-05-14
CA2291072C (en) 2002-08-20
SK283907B6 (sk) 2004-04-06
EA002770B1 (ru) 2002-08-29
HUP0002953A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
ES2149734T1 (es) Metodo para la preparacion de citalopram.
ES2170734B2 (es) Metodo para la preparacion de citalopram.
DE60332776D1 (de) Herstellung von Delta-9-Tetrahydrocannabinol
AR070946A2 (es) Proceso para la preparacion de dihidroxiesteres y derivados de los mismos
CA2397270A1 (en) Method for the preparation of 5-cyanophthalide
AR027559A1 (es) Metodo para la preparacion de citalopram
DE3767993D1 (de) Verfahren zur herstellung von thienylaethylaminen, und mittels des verfahrens hergestellte dithienylaethylamine.
ES2101410T3 (es) Un proceso para la preparacion de 1-substituido-5(4h)-tetrazolinonas.
AR029893A1 (es) Metodo para la preparacion de citalopram, intermediarios y composicion farmaceutica
ATE62243T1 (de) Verfahren zur herstellung eines optisch aktiven lactons und neue zwischenprodukte in diesem verfahren.
BRPI0406489A (pt) Método para a preparação de 2-difenilmetilsulfinilacetato de metila (mdmsa) e método para a preparação de modafinil
AR013876A1 (es) Un procedimiento para la produccion de acido clavulanico y sales farmaceuticamente aceptables del mismo
AR037493A1 (es) Proceso para la preparacion de hidrobromuro de citalopram
AR017180A1 (es) Metodo para la preparacion de citalopram
JPS5359645A (en) Preparation of benzonitriles
BR0312672A (pt) Processo para a preparação de compostos
RU94045824A (ru) Способ получения 3-карбониландростадиен-17-карбоксамидов
ATE274519T1 (de) Verfahren zur herstellung von gehinderten phosphiten
BG104486A (en) Method for the preparation of citalopram
JPS5334750A (en) Preparation of cyclopentadeca-4-yne-one
AR040502A1 (es) Proceso para la preparacion de la modificacion i de la torasemida por precipitacion con acidos a partir de un extracto alcalino de la mezcla de reaccion original de la ultima fase en la sintesis de la torasemida
AR005903A1 (es) Un proceso para la preparacion de clorhidrato en n(g)-monometil-l-arginina
JPS5212989A (en) Biochemical isolation of 1-menthol
DE69919132D1 (de) Verfahren zur herstellung von s-alkylcysteinen
ES2103163B1 (es) Un procedimiento para producir un compuesto aromatico por reaccion electrofilica.